Steven M. Fruchtman - 07 Feb 2024 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: PRESIDENT, CHIEF EXECUTIVE OFF, Director
Signature: /s/ Mark Guerin, Attorney-in-Fact
Issuer symbol: TRAW
Transactions as of: 07 Feb 2024
Net transactions value: -$6,172
Form type: 4
Filing time: 09 Feb 2024, 17:36:36 UTC
Previous filing: 04 Aug 2023
Next filing: 15 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+21,320	+44%		69,620	07 Feb 2024	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$6,172	-9,212	-13%	$0.6700	60,408	07 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-21,320	-50%	$0.000000	21,320	07 Feb 2024	Common Stock	21,320		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.